Abstract
Investigations on sleep have a long history. After the discovery of REM sleep (Aserinsky and Kleitmann 1953) interest in this phenomenon progressively increased. This interest was fostered when investigators noted that some CNS-active drugs changed the amount of REM sleep. An important group of such drugs is that of antidepressants. Subsequently the attention of many investigators has focused on this particular field. Studies testing the effects of antidepressants on sleep have been carried out in animals, normal humans, depressed patients and subjects suffering from other psychiatric disorders. The aims of these investigations have been heterogeneous and have included: evaluation of the effects of these drugs on sleep parameters; relationships between neurotransmitters and sleep regulation; drug classification based on their effects on sleep; and drug effects on sleep as indicators of treatment responsiveness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akindele M, Evans J, Oswald I (1970) Mono-amine oxidase inhibitors, sleep and mood. Electroenceph Clin Neurophysiol 29:47–56
Aserinsky E, Kleitmann N (1953) Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 188:273–274
Angst J, Theobold W, Bleuler M, Kuhn R (1970) Tofranil (imipramine). Stampfli, Bern
Bardeleben U, Steiger A, Gerken A, Holsboer F (1989) Effects of fluoxetine upon pharmacoendocrine and sleep EEG parameters in normal controls. Int Clin Psychopharmacol 4:1–5
Berger M, Riemann D (1993) REM sleep in depression: An overview. J Sleep Res 2:211–223
Berger M, Emrich H, Lund R, Riemann D, Lauer C, von Zerssen D (1986) Sleep-EEG variables as course criteria and predictors of antidepressant therapy with flauvxomine/oxoprotiline. In: Stille G, Wagner W, Herrmann W (eds) Advances in pharmacotherapy. Karger, Basel, pp 110–120
Bert J, Saier J, Dufour J, Scotto J, Julien R, Sutter J (1963) Modifications du sommeil provoquees par le lithium en administration aigue et en administration chronique. Electroencephalogr Clin Neurophysiol 15:599–609
Bohus M, Berger M (1992) Der Beitrag biologisch-psychiatrischer Befunde zum Verstaendnis depressiver Erkrankungen. Z Klin Psychol 2:156–171
Charney D, Heninger G, Sternberg D, Hafstad K, Giddings F, Landis H (1982) Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and controls. Arch Gen Psychiatry 39:290–294
Chernik D, Mendels J (1974) Longitudinal study of the effects of lithium carbonate on the sleep of hospitalized depressed patients. Biol Psychiatry 9(2): 117–123
Clark RW, Schmidt HS, Schaal SF, Boudoulas H, Schuller DE (1979) Sleep apnea treatment with protryptyline. Neurology 29:1287–1292
Coble P, Kupfer D, Spiker D, Neil J, McPartland R (1979) EEG sleep in primary depression: a longitudinal placebo study. J Affective Dis 1:131–138
Cohen R, Pickar D, Garnett D, Lipper S, Gillin C, Murphy D (1982) REM sleep suppression induced by selective monoamine oxidase inhibitors. Psychophar-macology 78:137–140
Di Perri R, Mailland F, Bramanti P (1986) The effects of amineptine and the mood and nocturnal sleep of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 11:65–70
Dijk D, Strijkstra A, Daan S, Beersma D, Van Den Hoofdakker R (1991) Effect of clomipramine on sleep and EEG power spectra in the diurnal rodent Eutamias sibiricus. Psychopharmacology 103:375–379
Dunleavy D, Oswald I (1973) Phenelzine, mood response, and sleep. Arch Gen Psychiatry 28:353–366
Dunleavy D, Brezinova V, Oswald I, Maclean A, Tinker M (1972) Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry 120:663–672
Feinberg I, Koresko R, Heller N, Steinberg H (1965) Unusually high dream time in a hallucinating patient. Am J Psychiatry 121:1018–1020
Friston J, Sharpley A, Solomon R, Cowen P (1989) Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors? Psychopharmacology 98: 139–140
Garcia-Sevilla J (1989) The platelet alpha-2 adrenoceptor as a potential marker in depression. Br J Psychiatry 154 [Suppl 4]:67–72
Garver DL, Davis JM (1979) Biogenic amine hypothesis of affective disorders. Life Sci 24:303–311
Garvey M, Mungas D, Tollefson G (1984) Hypersomnia in major depressive disorders. J Affective Disord 6:283–286
Gassicke J, Ashcroft G, Eccleston D, Evans J, Oswald I, Ritson E (1965) The clinical state, sleep and amine metabolism of a tranylcypromine (Parnate) addict. Br J Psychiatry III:357–364
Gigli G, Gotman J, Thomas S (1988) Sleep alterations after acute administration of carbamazepine in cats. Epilepsia 29(6):748–752
Gillin J, Wyatt R, Fram D, Snyder F (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267–272
Gillin J, Duncan W, Pettigrew K, Frankel B, Snyder F (1979) Successful separation of depressed, normal and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 36:85–90
Gillin J, Sitaram N, Wehr T et al. (1984) Sleep and affective illness. In: Post R, Ballenger J (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore, pp 157–189
Goldberg A (1983) The treatment of Kleine-Levin syndrome with lithium. Can J Psychiatry 28:491–493
Hart E (1985) Kleine-Levin syndrome: normal CSF monoamines and response to lithium therapy. Neurology 35:1395–1396
Hartmann E (1968a) Longitudinal studies of sleep and dream patterns in manic depressive patients. Arch Gen Psychiatry 19:312–329
Hartmann E (1968b) The effect of four drugs on sleep patterns in man. Psychopharmacologia 12:346–353
Hartmann E, Cravens J (1973) The effects of long term administration of psychotropic drugs on human sleep: III. The effects of amitriptyline. Psychopharmacologia 33:185–202
Hauri P, Hawkins D (1973) Individual differences in the sleep of depression. In: Jovanovic U (ed) The nature of sleep. Fischer, Stuttgart, pp 193–197
Hawkins D, Taub J, Van De Castle R (1985) Extended sleep (hypersomnia) in young depressed patients. Am J Psychiatry 142:905–910
Hilakivi L, Sinclair J (1984) Neonatal active sleep suppression by clomipramine and later alcohol related bahavior in rat. In: Koella W et al. (eds) Sleep 1984. Fischer, Stuttgart, pp 307–309
Hilakivi L, Stenberg D, Sinclair J, Kiianmaa K (1987) Neonatal desipramine or zimelidine treatment causes long-lasting changes in brain monaminergic systems and alcohol related behavior in rats. Psychpharmacology 91:403–409
Hill SY, Reyes RB, Kupfer DJ (1979) Physostigmine induction of REM sleep in imipramine treated rats. Community Psychopharmacol 3:261–266
Hill SY, Reyes RB, Kupfer DJ (1980) Imipramine and REM sleep. Cholinergic mediation in animals. Pyschopharmacology 69:5–9
Hishikawa Y, Nakai K, Idah, Kaneko Z (1965) The effect of imipramine, desmethy-limipramine and chlorpromazine on the sleep-wakefulness cycle of the cat. Electroencephalogr Clin Neurophysiology 19:518–521
Höchli D, Riemann D, Zulley J, Berger M (1986) Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry 21:1217–1220
Hoff P, Golling H, Kapfhammer R, Lund R, Pakesh E, Ruether E, Schmauss M (1986) Cimoxaton and moclobemid, two new MAO-inhibitors: influence on sleep parameters in patients with major depressive disorders. Pharmacopsychiatry 19:249–250
Hohagen F, Mayer G, Menche A, Riemann D, Volle S, Meier-Ewert KH, Berger M (1993) Treatment of narcolepsy-catoplexy-syndrome with brofaromine. J Sleep Res 2:250–256
Hohagen F, Fritsch-Montero R, Weiss E, Lis S, Schönbrunn E, Dressing H, Riemann D, Berger M (1994) Treatment of insomnia with trimipramine. Eur Arch Psychiatry Clin Neurosci 242:329–336
Hudson J, Lipinski J, Frankenburg F, Tohen M, Kupfer D (1989) Effects of lithium on sleep in mania. Biol Psychiatry 25:665–668
Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Psychopharmacol Biol Psychiatry 6:277–295
Insel T, Gillin C, Moore A, Wallace B, Löwenstein R, Murphy D (1982) The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 39:1372–1377
Itoh H, Kabashima T, Tamura M, Onda M, Takahashi T, Higuchi H, Sasaki M, Atsuyoshi M (1987) Lithium influence on nocturnal sleep and daytime sleepiness of normal subjects. Sleep Res 16:617
Jones H, Oswald I (1968) Two cases of healthy insomnia. Electroencephalogr Clin Neurophysiol 24:378–380
Jovanovic U, Schulte W (1978) Polygraphic sleep recordings in patients with endogenous depression before and after treatment with amitriptyline-n-oxide. Drug Res 28:1924–1925
Kales A, Malstrom EJ, Scharf MB, Rubin RT (1969) Psychophysiological and biochemical changes following use and withdrawal of hypnotics. In: Kales A (ed) Sleep physiology and pathology. Lippincott, Philadelphia, pp 331–343
Kales A, Cadieux RJ, Soldatos CR, Bixler EO, Schweitzer PK, Prey WT, Vela-Bueno A (1982) Narcolepsy-cataplexy, clinical and electrophysiologic characteristics. Arch Neurol 39:164–168
Katz J, Kuperberg A, Pollack C, Walsh B, Zumoff B, Weiner H (1984) Is there a relationship between eating disorder and affective disorder? New evidence from sleep recordings. Am J Psychiatry 141:753–759
Khazan H, Brown P (1970) Differential effects of three tricyclic antidepressants on sleep and REM sleep in the rat. Life Sci 9:279–284
Kiloh L, Garside R (1963) The independence of neurotic depression and endogenous depression. Br J Psychiatry 109:451–463
Kleinlogel H, Burki H (1987) Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimelidine on EEG sleep and waking stages in the rat. Neuropsychology 17:206–211
Kline NS (1958) Clinical experience with iproniacid (Marsilid). J Clin Exp Psychopathol 19 [Suppl]:72–78
Kripke D (1983) Phase advance theories for affective illnesses. In: Wehr TA, Goodwin FK (eds) Circadian rhythms in psychiatry. Boxwood, Pacific Grove, pp 41–69
Kruse W, Hoermann MG (1960) Clinical evaluation of four antidepressant drugs. Curr Ther Res 2:111–115
Kuhn R (1957) Ueber die Behandlung depressiver Zustaende mit einem Iminodibenzylderivat (G 22355). Schweiz Med Wochenschr 95:1135–1140
Kupfer D (1976) REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry 11:159–174
Kupfer D (1981) EEG sleep and tricyclic antidepressants in affective disorders. In: Usdin E (ed) Clinical pharmacology in psychiatry. Elsevier, New York, pp 325–338
Kupfer D (1982) Interaction of EEG sleep, antidepressants, and affective disease. J Clin Psychiatry 43(11):30–35
Kupfer D, Bowers M (1972) REM sleep and central monoamine oxidase inhibition. Psychopharmacologia 27:183–190
Kupfer D, Wyatt R, Greenspan K, Snyder F (1970) Lithium carbonate and sleep in affective illness. Arch Gen Psychiatry 23:35–40
Kupfer D, Reynolds C, Weiss B, Foster G (1974) Lithium carbonate and sleep in affective disorders. Arch Gen Psychiatry 30:79–84
Kupfer D, Reich L, Thompson K, Weiss B (1976) EEG sleep changes as predictors in depression. Am J Psychiatry 133:622–626
Kupfer D, Spiker D, Coble P, McPartland R (1978) Amitriptyline and EEG sleep in depressed patients: I. Drug effect. Sleep 1(2): 149–159
Kupfer D, Brondy D, Coble P, Spiker D (1980) EEG sleep and affective psychosis. J Affective Disord 2:17–25
Kupfer D, Spiker D, Coble P, Neil J, Ulrich R, Shaw D (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138(4):429–434
Kupfer D, Spiker D, Rossi A, Coble P, Shaw D, Ulrich R (1982) Nortriptyline and EEG sleep in depressed patients. Biol Psychiatry 17(5):535–546
Kupfer DJ, Shipley JM, Perel JM, Pollock B, Coble PA, Spiker DG (1987) Antidepressants and EEG sleep. Search for specificity. In: Dahl M, Gram P, Paul J, Potter W (eds) Clinical pharmacology in psychiatry. Springer, Berlin Heidelberg New York
Kupfer D, Ehlers D, Pollock B, Nathan S, Perel J (1989) Clomipramine and EEG sleep in depression. Psychiatry Res 30:165–180
Kupfer D, Perel J, Pollock B, Nathan R, Grochocinski V (1991a) Fluvoxamine versus desipramine: comparative polysomnographie effects. Biol Psychiatry 29:23–40.
Kupfer D, Pollock B, Perel J, Jarrett D, McEachran A, Miewald J (1991b) Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients. Psychiatry Res 36:279–289
Maas JW (1979) Neurotransmitters and depression: too much, too little, or too unstable? Trends Neurosci 2:306–308
Melzacka M, Danek L (1983) Pharmacokinetics of amitriptyline-n-oxide in rats after single prolonged oral administration. Pharmacopsychiatry 16:30–34
Mendels J, Chernik D (1973) The effect of lithium carbonate on the sleep of depressed patients. Int Pharmacopsychiatry 8:184–192
Mendels J, Hawkins D (1967) Sleep and depression A controlled EEG study. Arch Gen Psychiatry 19:445–452
Mirmiran M, Van De Poll N, Corner M, Van Oyen H, Bour H (1981) Suppression of active sleep by chronic treatment with clomipramine during postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204:129–146
Monti J, Alterwain P, Monti D (1990) The effects of moclobemide on nocturnal sleep of depressed patients. J Affective Dis 20:201–208
Mouret J, Lemoine P, Minuit M, Renardet M (1988) Interet des études polygra-phiques de sommeil dans le suivi des traitements antidepresseurs. Application à la trazodone. Psychiatr Psychobiol 3:29–36
Mouret J, Lemoine P, Minuit M, Sanchez P, Taillard J (1989) Sleep polygraphic effects of trimipramine in depressed patients. Drugs 38(1): 14–16
Nicholson A, Pascoe P (1988) Studies on the modulation of the sleep wakefulness continuum in man by fluoxetine 5-HT uptake inhibitor. Neuropharmacology 27:597–602
Ogura C, Okuma T, Nakazawa K, Kishimoto A (1976) Treatment of periodic somnolence with lithium carbonate. Arch Neurol 33:143
Oswald I (1969) Sleep and dependence on amphetamine and other drugs. In: Kales A (ed) Sleep physiology and pathology. B Lippincott, Philadelphia, pp 317–330
Oswald I, Adam K (1986) Effects of paroxetine on human sleep. Br J Clin Pharmacol 22:97–99
Poignant J (1979) Revue pharmacologique sur l’amineptine. Encephale V:709–720
Post R (1987) Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Meltzer H Y (ed) Psychopharmacology: the third generaton of progress. Raven, New York, pp 567–576
Reynolds CF III, Kupfer DJ (1987) Sleep research in effective illness. State of the art circulation 1988. Sleep 10:199–215
Riemann D Velthaus S, Laubenthal S, Mueller W, Berger M (1990) REM- suppressing effects of amitriptyline and amitriptyline-n-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials. Pharmacopsychiatry 23:253–258
Riemann D, Gann H, Fleckenstein P, Hohagen F, Olbrich R, Berger M (1991) Effect of RS 86 on REM latency in schizophrenia. Psychiatry Res 38:89–92
Riemann D, Gann H, Hohagen F, Bahro M, Müller W, Berger M (1993) The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls. Neuropsychobiology 27:163–170
Roth E, Smolik P, Soucek K (1980) Kleine-Levin syndrome lithoprophylaxis. Cesk Psychatr 76:156–162
Roy-Byrne P, Uhde T, Post R Joffe R (1984) Relationship of response to sleep deprivation and carbamazepine in depressed patients. Acta Psychiatr Scand 69:379–382
Saletu B (1976) Psychopharmaka und die Schlafqualitaet: quantitative neurophy-siologische und subjektive Parameter. Arzeneimittelforschung (Drug Res) 26(6): 1042–1047
Saletu B, Frey R, Kruphka M, Anderer P, Gruenberger J, See W (1991) Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 14(5):439–447
Scherschlicht R, Polc P, Schneeberger J, Steiner M, Haefely W (1982) Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven, New York, pp 264–359
Schildkraut J (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509
Sitaram N, Wyatt R, Dawson S, Gillin J (1976) REM sleep induction by physio-stigmine infusion during sleep. Science 1991:1281–1283
Sitaram N, Mendelson W, Wyatt R, Gillin J (1977) Time-dependent induction of REM sleep and arousal by physiostigmine infusion during normal human sleep. Brain Res 122:562–567
Snyder F (1972) NIH studies of EEG sleep in affective illness. In: Williams T, Katz M, Shields J (eds) Recent advances in the psychobiology of the depressive illnesses. US Government Printing Office, Washington DC, pp 171–192
Steiger A, Holsboer F, Benkert O (1987) Effects of brofaremine (CGP 11 305A), a short acting, reversible, and selective inhibitor of MAO-A on sleep, nocturnal penile tumescence and nocturnal hormonal secretion in three healthy volunteers. Psychopharmacology 92:110–114
Sugrue M (1980) Chronic antidepressant administration and adaptive changes in central monoaminergic system. In: Enna S, Malick J, Richelson E (eds) Antidepressants: neurochemical behavioral and clinical perspectives. Raven, New York
Sulser F, Mobley PL (1980) Biochemical effects of antidepressants in animals. In: Hoffmeister F, Stille G (eds) Psychotropic agents, part I. Springer, Berlin Heidelberg New York, pp 471–490 (Handbook of experimental pharmacology, vol 55)
Tandon R, Shipley J, Eiser A, Greden J (1988) Association between abnormal REM sleep and negative symptoms in schizophrenia. Psychiatry Res 27:359–361
Vogel G (1975) A review of REM sleep deprivation. Arch Gen Psychiatry 32:749–761
Vogel G (1983) Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry 7:343–349
Vogel G, Thurmond A, Gibbson P, Sloan K, Boyd M, Walker M (1975) REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32:749–761
Waldmeier PC (1981) Noradrenergic transmission in depression: under- or over-function? Pharmacopsychiatry 14:3–9
Ware C, Pittard J (1990) Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 51(9): 18–22
Ware J, Brown F, Moorad P, Pittard J, Cobert B (1985) Comparison of trimipramine and imipramine in depressed insomniac patients. Sleep Res 14:65
Wehr T, Wirz-Justice A (1982) Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatry 15:31–39
Wiegand M, Berger M (1989) Action of trimipramine on sleep and pituitary hormone secretion. Drugs 1:35–42
Wyatt R, Kupfer D, Scott J, Robinson D, Snyder F (1969) Longitudinal studies of the effect of monoamine oxidase inhibitors on sleep in man. Psychpharmacologia 15:236–224
Wyatt R, Fram D, Kupfer D, Snyder F (1971) Total prolonged drug-induced REM sleep suppression in anxious-depressed patients. Arch Gen Psychiatry 24: 145–155
Yang J, Elphick M, Sharpley A, Cowen P (1989) Effects of carbamazepine on sleep in healthy volunteers. Biol Psychiatry 26:324–328
Zarcone V, Benson K, Berger P (1987) Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 44:45–48
Zung W (1969) Antidepressant drugs and sleep. Exp Med Surg 27:124–137
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Montero, R.F., Riemann, D., Berger, M. (1995). Antidepressant and Antimanic Drugs. In: Kales, A. (eds) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57836-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-57836-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63372-0
Online ISBN: 978-3-642-57836-6
eBook Packages: Springer Book Archive